New Zealand markets closed
  • NZX 50

    11,594.94
    +8.01 (+0.07%)
     
  • NZD/USD

    0.6284
    +0.0060 (+0.97%)
     
  • ALL ORDS

    7,148.60
    -52.10 (-0.72%)
     
  • OIL

    70.64
    -0.26 (-0.37%)
     
  • GOLD

    1,977.20
    +27.60 (+1.42%)
     

Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback?

Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback?

Lilly's FDA rejection puts Biogen and its partner Eisai in the driver's seat in the Alzheimer's disease drug market.